LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
Hong Kong · Delayed Price · Currency is HKD 111.50
-2.80 (-2.45%)
Sep 10, 2026, 11:59 AM HKT
LongBio Pharma (Suzhou) Market Cap
LongBio Pharma (Suzhou) has a market cap or net worth of 8.48 billion as of September 9, 2026.
Market Cap
8.48B
Enterprise Value
7.13B
Revenue
2.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
111.50
ChartMarket Cap Chart
Since June 5, 2026, LongBio Pharma (Suzhou)'s market cap has decreased from 9.78B to 8.48B, a decrease of -13.28%. That is a compound annual growth rate of -41.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 8.48B | -6.08% |
| Sep 8, 2026 | 9.03B | 6.01% |
| Sep 7, 2026 | 8.52B | -10.31% |
| Sep 4, 2026 | 9.50B | 4.07% |
| Sep 3, 2026 | 9.13B | 8.95% |
| Sep 2, 2026 | 8.38B | 0.36% |
| Sep 1, 2026 | 8.35B | -7.48% |
| Aug 31, 2026 | 9.02B | -7.10% |
| Aug 28, 2026 | 9.71B | -0.53% |
| Aug 27, 2026 | 9.76B | 6.65% |
| Aug 26, 2026 | 9.16B | 2.41% |
| Aug 25, 2026 | 8.94B | 2.21% |
| Aug 24, 2026 | 8.75B | 2.61% |
| Aug 21, 2026 | 8.52B | -1.29% |
| Aug 20, 2026 | 8.64B | 10.65% |
| Aug 19, 2026 | 7.81B | -8.28% |
| Aug 18, 2026 | 8.51B | -7.05% |
| Aug 17, 2026 | 9.16B | 2.83% |
| Aug 14, 2026 | 8.90B | -6.40% |
| Aug 13, 2026 | 9.51B | 0.94% |
| Aug 12, 2026 | 9.42B | 2.01% |
| Aug 11, 2026 | 9.24B | 4.27% |
| Aug 10, 2026 | 8.86B | 5.66% |
| Aug 7, 2026 | 8.38B | 5.51% |
| Aug 6, 2026 | 7.95B | 2.10% |
| Aug 5, 2026 | 7.78B | 6.17% |
| Aug 4, 2026 | 7.33B | -0.20% |
| Aug 3, 2026 | 7.35B | 2.75% |
| Jul 31, 2026 | 7.15B | 16.36% |
| Jul 30, 2026 | 6.14B | -6.65% |
| Jul 29, 2026 | 6.58B | -8.65% |
| Jul 28, 2026 | 7.20B | -2.41% |
| Jul 27, 2026 | 7.38B | 11.61% |
| Jul 24, 2026 | 6.61B | -1.05% |
| Jul 23, 2026 | 6.68B | 2.39% |
| Jul 22, 2026 | 6.53B | 3.65% |
| Jul 21, 2026 | 6.30B | -6.86% |
| Jul 20, 2026 | 6.76B | 6.55% |
| Jul 17, 2026 | 6.35B | -5.16% |
| Jul 16, 2026 | 6.69B | 1.52% |
| Jul 15, 2026 | 6.59B | 7.05% |
| Jul 14, 2026 | 6.16B | -4.60% |
| Jul 13, 2026 | 6.45B | -10.49% |
| Jul 10, 2026 | 7.21B | 8.18% |
| Jul 9, 2026 | 6.67B | -5.47% |
| Jul 8, 2026 | 7.05B | -12.07% |
| Jul 7, 2026 | 8.02B | 0.65% |
| Jul 6, 2026 | 7.97B | 1.23% |
| Jul 3, 2026 | 7.87B | 0.19% |
| Jul 2, 2026 | 7.86B | -29.82% |
| Jun 30, 2026 | 11.20B | -0.07% |
| Jun 29, 2026 | 11.20B | 0.67% |
| Jun 26, 2026 | 11.13B | -4.58% |
| Jun 25, 2026 | 11.66B | 3.63% |
| Jun 24, 2026 | 11.26B | -1.49% |
| Jun 23, 2026 | 11.43B | -0.19% |
| Jun 22, 2026 | 11.45B | 8.05% |
| Jun 18, 2026 | 10.59B | 2.00% |
| Jun 17, 2026 | 10.39B | -1.62% |
| Jun 16, 2026 | 10.56B | -0.35% |
| Jun 15, 2026 | 10.59B | -0.76% |
| Jun 12, 2026 | 10.68B | 1.41% |
| Jun 11, 2026 | 10.53B | 3.20% |
| Jun 10, 2026 | 10.20B | -1.65% |
| Jun 9, 2026 | 10.37B | 12.74% |
| Jun 8, 2026 | 9.20B | -5.92% |
| Jun 5, 2026 | 9.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 10.98B |
| Ascletis Pharma | 10.63B |
| Suzhou Ribo Life Science | 9.84B |
| CStone Pharmaceuticals | 9.83B |
| GenFleet Therapeutics (Shanghai) | 9.74B |
| Shaanxi Micot Pharmaceutical Technology | 8.64B |
| Alphamab Oncology | 8.18B |
| TenNor Therapeutics (Suzhou) | 7.84B |